Order Article Reprints

Belosludtsev KN, Serov DA, Ilzorkina AI, Starinets VS, Dubinin MV, Talanov EY, Karagyaur MN, Primak AL, Belosludtseva NV. Pharmacological and Genetic Suppression of VDAC1 Alleviates the Development of Mitochondrial Dysfunction in Endothelial and Fibroblast Cell Cultures upon Hyperglycemic Conditions. Antioxidants. 2023; 12(7):1459. https://doi.org/10.3390/antiox12071459

Belosludtsev, Konstantin N., Dmitriy A. Serov, Anna I. Ilzorkina, Vlada S. Starinets, Mikhail V. Dubinin, Eugeny Yu. Talanov, Maxim N. Karagyaur, Alexandra L. Primak, and Natalia V. Belosludtseva. 2023. "Pharmacological and Genetic Suppression of VDAC1 Alleviates the Development of Mitochondrial Dysfunction in Endothelial and Fibroblast Cell Cultures upon Hyperglycemic Conditions" Antioxidants 12, no. 7: 1459. https://doi.org/10.3390/antiox12071459

Belosludtsev, K. N., Serov, D. A., Ilzorkina, A. I., Starinets, V. S., Dubinin, M. V., Talanov, E. Y., Karagyaur, M. N., Primak, A. L., & Belosludtseva, N. V. (2023). Pharmacological and Genetic Suppression of VDAC1 Alleviates the Development of Mitochondrial Dysfunction in Endothelial and Fibroblast Cell Cultures upon Hyperglycemic Conditions. Antioxidants, 12(7), 1459. https://doi.org/10.3390/antiox12071459